CLINICAL_TRIALS ClinicalTrials.gov record update

GD2-CAR PERSIST: Production and Engineering of GD2-Targeted, Receptor Modified T Cells (GD2CART) for Osteosarcoma or Neuroblastoma to Increase Systemic Tumor Exposure

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04539366
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:29:00.258405+00:00
Published At: 2025-11-03T00:00:00+00:00
Record Updated At: 2025-11-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Recurrent Childhood Neuroblastoma", "Recurrent Childhood Osteosarcoma", "Recurrent Neuroblastoma", "Recurrent Osteosarcoma", "Refractory Childhood Neuroblastoma", "Refractory Childhood Osteosarcoma", "Refractory Neuroblastoma", "Refractory Osteosarcoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-11-03"
protocolSection.identificationModule.nctId: "NCT04539366"
protocolSection.identificationModule.officialTitle: "GD2-CAR PERSIST: Production and Engineering of GD2-Targeted, Receptor Modified T Cells (GD2CART) for Osteosarcoma or Neuroblastoma to Increase Systemic Tumor Exposure"
protocolSection.statusModule.overallStatus: "SUSPENDED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.